BOSTON & MOJAVE, Calif.--(BUSINESS WIRE)--Merlin, the leading developer of safe, autonomous flight technology for fixed-wing aircraft, today announced it successfully began the flight test campaign of ...

BOSTON--(BUSINESS WIRE)--Merlin, the leading developer of assured autonomous flight technology for fixed-wing aircraft, today announced it’s rapidly progressing the flight test campaign of its ...

SkylineDx said its Merlin CP-GEP molecular test is uniquely recognized by the National Comprehensive Cancer Network (NCCN) for predictive use in select T1 and T2 melanoma patients. The test provides ...

Please provide your email address to receive an email when new articles are posted on . The Merlin test, a clinical-pathologic and gene expression profile, was able to successfully classify 37% of ...

Merlin has obtained an Experimental Certificate of Airworthiness from the Civil Aviation Authority of New Zealand (CAANZ), enabling the company to commence certification flight testing of its ...

SkylineDx said its Merlin CP-GEP molecular test identifies a subset of T1a melanoma patients with sentinel lymph node (SLN) positivity above guideline thresholds. The National Comprehensive Cancer ...

Merlin and SNC conducted the first flight tests for the U.S. Air Force's KC-135 automation program at the Pittsburgh Air National Guard Base in Pennsylvania.

Merlin CP-GEP is the only molecular test recognized by NCCN as predictive and appropriate for use in select T1 and T2 patients to support shared decision-making regarding Sentinel Lymph Node Biopsy.

Merlin’s autonomous flight system will initially be used to assist the single pilot in a Caravan on cargo routes. Credit: Merlin U.S. startup Merlin has received an experimental airworthiness ...